ATAGI recommends COVID-19 Pfizer vaccine over the AstraZeneca vaccine for adults aged under 50 years.
8 April 2021
As of 8 April 2021, the Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the COVID-19 Pfizer vaccine is preferred over the AstraZeneca vaccine for adults aged under 50 years. ATAGI has considered the latest vaccination findings out of Europe and the UK – which follow extremely rare instances of people, having taken the AstraZeneca vaccine, developing […]
Continue Reading
